Abstract
Introduction
Majority of the studies comparing Roux en Y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB) are non-randomized. Moreover, few randomized studies have focussed on weight loss as the primary outcome rather than the impact on type 2 diabetes mellitus (T2DM). This randomized trial compared OABG over RYGB with the hypothesis that OAGB is not inferior to RYGB in terms of remission of T2DM.
Methods
This was an open-labelled, randomized trial in which patients having a BMI greater than 30 kg/m2 with T2DM were included. The primary outcome was the remission of T2DM.
Results
In the study, 25 and 24 patients were recruited in OAGB and RYGB groups respectively. The remission rates of T2DM were similar at all timelines. The highest rate was achieved at 1 year (86.36% vs 85.71%) for both the groups and a 4-year remission rate of (72.22% vs 71.43%), for OAGB vs RYGB respectively. The % EWL was also comparable with the highest rate achieved again at 1 year (69.23% vs 66.67%) and a 4-year rate of (58.33% vs 53.33%), for OAGB vs RYGB respectively. Remission of other co-morbidities, major and minor complication rate, re-admission rate, and nutritional issues were similar in both groups.
Conclusion
OAGB is non-inferior to RYGB in terms of remission of type 2 diabetes mellitus, weight loss, and early and late complications with a shorter operating time.
Graphical Abstract
Similar content being viewed by others
Data Availability
All data generated or analysed during this study are included in this published article.
References
Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-En Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–85.
Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.
Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308(11):1122–31.
DeMaria EJ, Pate V, Warthen M, et al. Baseline data from American Society for metabolic and bariatric surgery-designated bariatric surgery centers of excellence using the bariatric outcomes longitudinal database. Surg Obes Relat Dis. 2010;6(4):347–55.
Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: a meta-analysis. Clin Obes. 2018;8(3):159–69.
Alkhalifah N, Lee WJ, Hai TC, et al. 15-year experience of laparoscopic single anastomosis (mini-)gastric bypass: comparison with other bariatric procedures. Surg Endosc. 2018;32(7):3024–31.
Level L, Rojas A, Piñango S, et al. One anastomosis gastric bypass vs. Roux-en-Y gastric bypass: a 5-year follow-up prospective randomized trial. Langenbecks Arch Surg. 2021;406(1):171–9.
Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y Versus mini-gastric bypass for the treatment of morbid obesity. Ann Surg. 2005;242(1):20–8.
Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. The Lancet. 2019;393(10178):1299–309.
Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489–506.
Borgeraas H, Hofsø D, Hertel JK, et al. Comparison of the effect of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Obes Rev Off J Int Assoc Study Obes. 2020;21(6):e13011.
Purnell JQ, Dewey EN, Laferrère B, et al. Diabetes remission status during seven-year follow-up of the longitudinal assessment of bariatric surgery study. J Clin Endocrinol Metab. 2021;106(3):774–88.
Moradi M, Kabir A, Khalili D, et al. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study. BMC Endocr Disord. 2022;22(1):260.
Almalki OM, Lee WJ, Chong K, et al. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2018;14(4):509–15.
Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity. Ann Surg. 2005;242(1):20–8.
Mahawar KK, Jennings N, Brown J, et al. Small PK. “Mini” gastric bypass: systematic review of a controversial procedure. Obes Surg. 2013;23(11):1890–8.
Author information
Authors and Affiliations
Contributions
Author Contribution
Contributor 1 | Contributor 2 | Contributor 3 | Contributor 4 | Contributor 5 | Contributor 6 | Contributor 7 | Contributor 8 | |
---|---|---|---|---|---|---|---|---|
Concept | ✓ | |||||||
Design | ✓ | ✓ | ✓ | |||||
Definition of content | ✓ | ✓ | ✓ | |||||
Literature search | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Clinical studies | ✓ | ✓ | ✓ | |||||
Data and statistical analysis | ✓ | ✓ | ✓ | |||||
Data acquisition | ✓ | ✓ | ✓ | ✓ | ✓ | |||
Manuscript preparation | ✓ | ✓ | ✓ | |||||
Manuscript editing | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Manuscript review | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Guarantor | ✓ | ✓ |
Corresponding author
Ethics declarations
Ethics Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to Participate
A formal informed consent was obtained from all individual participants included in the study.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• OAGB is a technically easier procedure with a shorter operative time.
• OAGB is not inferior to RYGB in terms of remission of T2DM.
• OAGB may be a preferred option over RYGB in patients with morbid obesity and T2DM.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Singh, B., Saikaustubh, Y., Singla, V. et al. One Anastomosis Gastric Bypass (OAGB) vs Roux en Y Gastric Bypass (RYGB) for Remission of T2DM in Patients with Morbid Obesity: a Randomized Controlled Trial. OBES SURG 33, 1218–1227 (2023). https://doi.org/10.1007/s11695-023-06515-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06515-4